Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis-Reference-Cited by-同舟云学术

Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis

Published:2001-04 Issue:1 Volume:2 Page:47-51
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Spielmann Marc,Martin Miguel,Namer Moïse,duBois Andreas,Unger Clemens,Dodwell David J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Treatment of breast cancer;Hortobagyi;N Engl J Med,1998

2. LY231514, a pyrrolo[2,3-d] pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes;Shih;Cancer Res,1997

3. LY231514, a novel pyrolopyrimidine antifolate that inhibits thymidylate synthase (TS);Grindey;Proc Annu Meet Am Assoc Cancer Res,1992

4. 5-Fluoropyrimidines;Grem,1996

5. Antimetabolites;Schilsky,1992

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance;Molecular Diversity;2019-10-28

2. Potential role of pemetrexed in metastatic breast cancer patients pre-treated with anthracycline or taxane;Chronic Diseases and Translational Medicine;2015-03

3. Néphrotoxicité du pemetrexed;Bulletin du Cancer;2015-02

4. Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids;Biological & Pharmaceutical Bulletin;2015

5. A Phase II Multicenter Study of Two Different Dosages of Pemetrexed Given in Combination With Cyclophosphamide as First-Line Treatment in Patients With Locally Advanced or Metastatic Breast Cancer;Cancer Investigation;2012-04-02